Pharma Pulse 11/14/24: Powering Pipelines Forward, Debates Continue About Pharmacists’ Provider Status & more

Powering Pipelines Forward: Approach Science Differently

Why tapping the value generated for the next set of therapies is critical.

Debates Continue About Pharmacists’ Provider Status

Despite their proven abilities, organizations such as the American Medical Association still oppose so-called “scope creep.”

So Human It’s Scary: My Day Alone Talking to Bots That Sound Like Us

Joanna Stern strapped chatbots from Meta, Google, OpenAI and Microsoft to a tripod and took them to the woods to uncover the secrets of AI friendship.

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue

Hims & Hers Health, Inc. shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need.

Matt Sample on LinkedIn

I really want to thank the FDA for listening to the industry, the experts, and the ones striving to get medicines to those in need.

To my friends in manufacturing, this isn't a pause, this is a time to put quality processes in place to ensure we don't impact patient access. I don't want a bad barcode to come in-between me and getting a drug to a patient in need!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs